Cinamolol

This classification denotes a beta-adrenergic blocking agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7531Q8398Y. European Medicines Agency schedules Cinamolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06284MIG. Cinamolol generally arises in the molecular formula C16H23NO4. The term CINAMOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, no. 5 1981, list 21.) CINAMOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cinamolol under HS 29221980 and SITC 51461. As of Q4 2014, CINAMOLOL remains the US FDA Preferred Term for this commodity. Cinamolol bears US NLM identifiers UMLS ID C2699218 and NCI Concept Code C77942. SMILES: O(CC(O)CNC(C)C)C1C(CCCC1)/C=C/C(=O)OC.